Goldman Sachs’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,249
| Closed | -$225K | – | 5518 |
|
|
2020
Q4 | $225K | Buy |
+12,249
| New | +$225K | ﹤0.01% | 4221 |
|
|
2018
Q2 | – | Sell |
-52,843
| Closed | -$927K | – | 4385 |
|
|
2018
Q1 | $927K | Buy |
+52,843
| New | +$927K | ﹤0.01% | 3229 |
|
|
2017
Q3 | – | Sell |
-61,733
| Closed | -$540K | – | 4484 |
|
|
2017
Q2 | $540K | Buy |
+61,733
| New | +$540K | ﹤0.01% | 3501 |
|
|
2016
Q3 | – | Sell |
-18,703
| Closed | -$224K | – | 4678 |
|
|
2016
Q2 | $224K | Buy |
+18,703
| New | +$224K | ﹤0.01% | 3798 |
|
|
2015
Q1 | – | Sell |
-11,798
| Closed | -$152K | – | 4680 |
|
|
2014
Q4 | $152K | Sell |
11,798
-8,252
| -41% | -$106K | ﹤0.01% | 4105 |
|
|
2014
Q3 | $421K | Buy |
+20,050
| New | +$421K | ﹤0.01% | 3440 |
|